| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 2.42e-09 | 158 | 68 | 9 | GO:0050684 | |
| GeneOntologyBiologicalProcess | mRNA processing | MFAP1 CACTIN RBM25 SFPQ SAFB PRPF40B SLTM SAFB2 CDK11A PRPF6 UPF3B CDK11B SNRNP70 CWC22 | 2.62e-09 | 551 | 68 | 14 | GO:0006397 |
| GeneOntologyBiologicalProcess | mRNA metabolic process | MFAP1 CACTIN RBM25 SFPQ SAFB PRPF40B SLTM SAFB2 CDK11A GIGYF2 PRPF6 UPF3B CDK11B SNRNP70 CWC22 | 2.28e-07 | 917 | 68 | 15 | GO:0016071 |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | RBM25 SAFB SLTM SAFB2 CDK11A GIGYF2 UPF3B CDK11B SNRNP70 CWC22 | 1.80e-06 | 443 | 68 | 10 | GO:1903311 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 2.59e-06 | 358 | 68 | 9 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.59e-06 | 358 | 68 | 9 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.83e-06 | 362 | 68 | 9 | GO:0000375 | |
| GeneOntologyBiologicalProcess | RNA splicing | 3.84e-05 | 502 | 68 | 9 | GO:0008380 | |
| GeneOntologyBiologicalProcess | RNA processing | MFAP1 CACTIN RBM25 SFPQ SAFB PRPF40B SLTM SAFB2 CDK11A PRPF6 UPF3B CDK11B SNRNP70 CWC22 ELAC2 | 8.84e-05 | 1500 | 68 | 15 | GO:0006396 |
| GeneOntologyBiologicalProcess | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 1.06e-04 | 5 | 68 | 2 | GO:1904261 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane assembly involved in embryonic body morphogenesis | 1.06e-04 | 5 | 68 | 2 | GO:1904259 | |
| GeneOntologyBiologicalProcess | basement membrane assembly involved in embryonic body morphogenesis | 1.06e-04 | 5 | 68 | 2 | GO:2001197 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion, centromeric | 2.23e-04 | 7 | 68 | 2 | GO:0071962 | |
| GeneOntologyBiologicalProcess | mRNA cis splicing, via spliceosome | 5.01e-04 | 47 | 68 | 3 | GO:0045292 | |
| GeneOntologyCellularComponent | cell cortex region | 1.38e-05 | 45 | 68 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 1.60e-05 | 97 | 68 | 5 | GO:0005684 | |
| GeneOntologyCellularComponent | nuclear body | CACTIN RBM25 SFPQ PRPF40B SLTM SAFB2 PRPF6 RERE SNRNP70 PSPC1 CWC22 INO80B | 3.07e-05 | 903 | 68 | 12 | GO:0016604 |
| GeneOntologyCellularComponent | actomyosin | 3.97e-05 | 117 | 68 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 4.65e-05 | 61 | 68 | 4 | GO:0000307 | |
| GeneOntologyCellularComponent | spliceosomal complex | 7.10e-05 | 215 | 68 | 6 | GO:0005681 | |
| GeneOntologyCellularComponent | nuclear speck | 7.67e-05 | 431 | 68 | 8 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MFAP1 CACTIN SFPQ PRPF40B FOS BRD4 PRPF6 UPF3B RERE SNRNP70 MGA CWC22 TAF1L INO80B | 1.16e-04 | 1377 | 68 | 14 | GO:0140513 |
| GeneOntologyCellularComponent | cell cortex | 2.00e-04 | 371 | 68 | 7 | GO:0005938 | |
| GeneOntologyCellularComponent | basal cortex | 2.17e-04 | 7 | 68 | 2 | GO:0045180 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 4.11e-04 | 107 | 68 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 4.11e-04 | 107 | 68 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | paraspeckles | 4.61e-04 | 10 | 68 | 2 | GO:0042382 | |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 4.61e-04 | 10 | 68 | 2 | GO:0042564 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 5.47e-04 | 576 | 68 | 8 | GO:0015629 | |
| GeneOntologyCellularComponent | actin filament bundle | 5.95e-04 | 118 | 68 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | U2-type precatalytic spliceosome | 6.13e-04 | 51 | 68 | 3 | GO:0071005 | |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 6.74e-04 | 12 | 68 | 2 | GO:0031074 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 7.25e-04 | 54 | 68 | 3 | GO:0071011 | |
| GeneOntologyCellularComponent | centrosome | 8.39e-04 | 770 | 68 | 9 | GO:0005813 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.12e-03 | 360 | 68 | 6 | GO:0099568 | |
| GeneOntologyCellularComponent | U2-type prespliceosome | 1.54e-03 | 18 | 68 | 2 | GO:0071004 | |
| GeneOntologyCellularComponent | prespliceosome | 1.54e-03 | 18 | 68 | 2 | GO:0071010 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.72e-03 | 157 | 68 | 4 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 2.29e-03 | 170 | 68 | 4 | GO:1902911 | |
| GeneOntologyCellularComponent | microtubule organizing center | 2.83e-03 | 919 | 68 | 9 | GO:0005815 | |
| GeneOntologyCellularComponent | spliceosomal snRNP complex | 3.79e-03 | 96 | 68 | 3 | GO:0097525 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 3.90e-03 | 97 | 68 | 3 | GO:0071013 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 4.69e-03 | 335 | 68 | 5 | GO:0061695 | |
| GeneOntologyCellularComponent | MLL1 complex | 4.86e-03 | 32 | 68 | 2 | GO:0071339 | |
| GeneOntologyCellularComponent | small nuclear ribonucleoprotein complex | 5.13e-03 | 107 | 68 | 3 | GO:0030532 | |
| GeneOntologyCellularComponent | U1 snRNP | 5.16e-03 | 33 | 68 | 2 | GO:0005685 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 5.16e-03 | 33 | 68 | 2 | GO:0044665 | |
| Domain | - | RBM25 SFPQ SAFB SLTM SAFB2 UPF3B SNRNP70 PSPC1 TMEM63A ENOX2 | 2.40e-08 | 244 | 70 | 10 | 3.30.70.330 |
| Domain | Nucleotide-bd_a/b_plait | RBM25 SFPQ SAFB SLTM SAFB2 UPF3B SNRNP70 PSPC1 TMEM63A ENOX2 | 4.07e-08 | 258 | 70 | 10 | IPR012677 |
| Domain | RRM_1 | 1.08e-06 | 208 | 70 | 8 | PF00076 | |
| Domain | RRM | 1.48e-06 | 217 | 70 | 8 | SM00360 | |
| Domain | RRM_dom | 2.08e-06 | 227 | 70 | 8 | IPR000504 | |
| Domain | RRM | 2.29e-06 | 230 | 70 | 8 | PS50102 | |
| Domain | NOPS | 4.14e-05 | 3 | 70 | 2 | PF08075 | |
| Domain | NOPS | 4.14e-05 | 3 | 70 | 2 | IPR012975 | |
| Domain | PRKG1_interact | 4.14e-05 | 3 | 70 | 2 | IPR031775 | |
| Domain | PRKG1_interact | 4.14e-05 | 3 | 70 | 2 | PF15898 | |
| Domain | MYPT1/MYPT2_chordates | 4.14e-05 | 3 | 70 | 2 | IPR017401 | |
| Domain | - | 6.39e-05 | 21 | 70 | 3 | 1.10.720.30 | |
| Domain | SAP | 7.38e-05 | 22 | 70 | 3 | PF02037 | |
| Domain | SAP | 8.46e-05 | 23 | 70 | 3 | SM00513 | |
| Domain | SAP | 1.09e-04 | 25 | 70 | 3 | PS50800 | |
| Domain | SAP_dom | 1.09e-04 | 25 | 70 | 3 | IPR003034 | |
| Domain | Arm_3 | 2.87e-04 | 7 | 70 | 2 | PF16186 | |
| Domain | Importing_su_alpha | 2.87e-04 | 7 | 70 | 2 | IPR024931 | |
| Domain | Arm_3 | 2.87e-04 | 7 | 70 | 2 | IPR032413 | |
| Domain | IBB | 2.87e-04 | 7 | 70 | 2 | PF01749 | |
| Domain | IBB | 3.82e-04 | 8 | 70 | 2 | PS51214 | |
| Domain | Importin-a_IBB | 4.90e-04 | 9 | 70 | 2 | IPR002652 | |
| Domain | - | 3.44e-03 | 391 | 70 | 6 | 2.30.29.30 | |
| Domain | Bromodomain_CS | 4.25e-03 | 26 | 70 | 2 | IPR018359 | |
| Domain | PH_dom-like | 5.21e-03 | 426 | 70 | 6 | IPR011993 | |
| Domain | Arm | 6.00e-03 | 31 | 70 | 2 | PF00514 | |
| Domain | BROMODOMAIN_1 | 8.47e-03 | 37 | 70 | 2 | PS00633 | |
| Domain | ARM-type_fold | 8.84e-03 | 339 | 70 | 5 | IPR016024 | |
| Domain | Bromodomain | 8.92e-03 | 38 | 70 | 2 | PF00439 | |
| Domain | - | 9.66e-03 | 222 | 70 | 4 | 1.25.10.10 | |
| Domain | ARM_REPEAT | 9.85e-03 | 40 | 70 | 2 | PS50176 | |
| Domain | ARM | 9.85e-03 | 40 | 70 | 2 | SM00185 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.08e-05 | 201 | 54 | 7 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.53e-05 | 212 | 54 | 7 | M14033 | |
| Pathway | WP_MRNA_PROCESSING | 4.79e-05 | 451 | 54 | 9 | MM15946 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 6.73e-05 | 21 | 54 | 3 | M27494 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 8.43e-05 | 277 | 54 | 7 | MM15414 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 8.91e-05 | 23 | 54 | 3 | MM15222 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 9.64e-05 | 283 | 54 | 7 | M13087 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | MFAP1 RBM25 SFPQ SAFB CALD1 PRRC2C BRD4 SLTM SAFB2 CDK11A GIGYF2 PRPF6 CDK11B SNRNP70 MGA PSPC1 CWC22 TAF1L INO80B | 3.02e-14 | 954 | 70 | 19 | 36373674 |
| Pubmed | MFAP1 RBM25 SFPQ SAFB CALD1 NF2 MYO6 PPP1R12A SAFB2 CDK11A KPNA6 PRPF6 EIF3A SNRNP70 CWC22 PHLDB2 | 2.27e-13 | 660 | 70 | 16 | 32780723 | |
| Pubmed | MFAP1 CACTIN RBM25 SFPQ LRCH2 CALD1 MYO6 BRD4 ENAH KPNA6 PRPF6 SNRNP70 PSPC1 LRRFIP2 | 1.46e-12 | 506 | 70 | 14 | 30890647 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | CACTIN RBM25 SFPQ SAFB CALD1 NF2 MYO6 PPP1R12A PPP1R12B SLTM SAFB2 CDK11A PRPF6 EIF3A UPF3B CDK11B LRRFIP2 | 4.54e-12 | 949 | 70 | 17 | 36574265 |
| Pubmed | MAP7D1 SFPQ LRCH2 PRRC2C PPP1R12A ENAH SAFB2 GIGYF2 GRIA3 JAKMIP1 PPFIA3 CCDC6 MGA CCDC177 CDC42BPB PHLDB2 LRRFIP2 | 5.72e-12 | 963 | 70 | 17 | 28671696 | |
| Pubmed | MFAP1 CACTIN MAP7D1 SFPQ BRD4 KPNA6 PRPF6 SNRNP70 PSPC1 CWC22 INO80B | 2.26e-11 | 300 | 70 | 11 | 28561026 | |
| Pubmed | PHLDB1 MAP7D1 SFPQ SAFB LRCH2 CALD1 ARHGAP23 MYO6 PRRC2C PPP1R12A PPP1R12B EIF3A UPF3B CGNL1 PPFIA3 PSPC1 CCDC177 CDC42BPB LRRFIP2 | 3.59e-11 | 1431 | 70 | 19 | 37142655 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | MFAP1 CACTIN RBM25 SFPQ SAFB PRRC2C SLTM SAFB2 GIGYF2 EIF3A UPF3B CDK11B SNRNP70 PSPC1 ELAC2 | 5.90e-11 | 807 | 70 | 15 | 22681889 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.80e-10 | 283 | 70 | 10 | 30585729 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | STK10 MFAP1 CACTIN RBM25 SAFB GSE1 BRD4 SAFB2 CDK11A GIGYF2 CDK11B RERE CCDC6 PHLDB2 | 3.98e-10 | 774 | 70 | 14 | 15302935 |
| Pubmed | KPNA5 RBM25 PPP1R12B BRD4 SLTM SAFB2 PRPF6 EIF3A UBXN1 SNRNP70 PHLDB2 | 5.18e-10 | 403 | 70 | 11 | 35253629 | |
| Pubmed | MFAP1 CACTIN MAP7D1 RBM25 GSE1 ARHGAP23 PRPF40B MTHFR PPP1R12A BRD4 KPNA6 RERE PPFIA3 MGA INO80B PHLDB2 | 5.54e-10 | 1116 | 70 | 16 | 31753913 | |
| Pubmed | MFAP1 RBM25 SFPQ SAFB PPP1R12A SLTM SAFB2 GIGYF2 PRPF6 EIF3A SNRNP70 PSPC1 INO80B LRRFIP2 | 1.27e-09 | 847 | 70 | 14 | 35850772 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MFAP1 PHLDB1 RBM25 SFPQ SAFB CALD1 SLTM SAFB2 GIGYF2 PRPF6 EIF3A SNRNP70 MGA PSPC1 PHLDB2 | 1.56e-09 | 1024 | 70 | 15 | 24711643 |
| Pubmed | MAP7D1 RBM25 SFPQ SAFB PRRC2C SLTM SAFB2 PRPF6 UPF3B CDK11B SNRNP70 ELAC2 LRRFIP2 | 1.65e-09 | 713 | 70 | 13 | 29802200 | |
| Pubmed | MFAP1 PHLDB1 RBM25 SFPQ SAFB PRRC2C SLTM SAFB2 PRPF6 EIF3A SNRNP70 PSPC1 CWC22 | 2.22e-09 | 731 | 70 | 13 | 29298432 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | PHLDB1 MAP7D1 SAFB GSE1 PRRC2C SLTM EIF3A UPF3B SNRNP70 PHLDB2 | 2.93e-09 | 361 | 70 | 10 | 26167880 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MFAP1 MAP7D1 RBM25 SFPQ SAFB MYO6 PRRC2C PPP1R12A SLTM SAFB2 PRPF6 EIF3A PSPC1 CWC22 PHLDB2 LRRFIP2 | 3.04e-09 | 1257 | 70 | 16 | 36526897 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | KPNA5 MAP7D1 LRCH2 MYO6 PPP1R12B BRD4 GIGYF2 KPNA6 EIF3A JAKMIP1 CEP128 PHLDB2 LRRFIP2 | 3.21e-09 | 754 | 70 | 13 | 33060197 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MFAP1 CACTIN MAP7D1 RBM25 MYO6 PPP1R12A KPNA6 ODAD4 PRPF6 EIF3A CDK11B UBXN1 CCDC6 SNRNP70 CDC42BPB ELAC2 | 4.11e-09 | 1284 | 70 | 16 | 17353931 |
| Pubmed | 4.41e-09 | 66 | 70 | 6 | 23472066 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | MAP7D1 SFPQ SAFB BRD4 SLTM KPNA6 PRPF6 SNRNP70 PSPC1 TMEM63A | 1.01e-08 | 411 | 70 | 10 | 35182466 |
| Pubmed | MFAP1 CACTIN RBM25 SFPQ SAFB BRD4 SLTM SAFB2 PRPF6 EIF3A CDK11B UBXN1 PSPC1 ELAC2 | 1.24e-08 | 1014 | 70 | 14 | 32416067 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RBM25 SFPQ SAFB MYO6 ENAH SLTM SAFB2 GIGYF2 KPNA6 PRPF6 EIF3A UPF3B SNRNP70 PSPC1 CWC22 LRRFIP2 | 1.78e-08 | 1425 | 70 | 16 | 30948266 |
| Pubmed | 1.95e-08 | 441 | 70 | 10 | 31239290 | ||
| Pubmed | MFAP1 MAP7D1 SFPQ SAFB CALD1 PRRC2C PPP1R12A PPP1R12B SAFB2 GRIA3 PRPF6 EIF3A JAKMIP1 PSPC1 CEP128 CCDC191 | 2.10e-08 | 1442 | 70 | 16 | 35575683 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.76e-08 | 154 | 70 | 7 | 16055720 | |
| Pubmed | MFAP1 MAP7D1 RBM25 LRCH2 CALD1 ARHGAP23 PPP1R12A ENAH PRPF6 CCDC6 SNRNP70 MGA PSPC1 | 3.20e-08 | 916 | 70 | 13 | 32203420 | |
| Pubmed | 3.40e-08 | 244 | 70 | 8 | 29884807 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SFPQ SAFB GSE1 CALD1 MYO6 PRRC2C PPP1R12A ENAH SAFB2 GIGYF2 EIF3A UPF3B CGNL1 | 4.01e-08 | 934 | 70 | 13 | 33916271 |
| Pubmed | 4.22e-08 | 251 | 70 | 8 | 31076518 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MFAP1 CACTIN RBM25 SFPQ SAFB GSE1 SAFB2 KPNA6 PRPF6 EIF3A CDK11B UBXN1 SNRNP70 PSPC1 CWC22 | 4.49e-08 | 1318 | 70 | 15 | 30463901 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | KPNA5 RBSN SFPQ CALD1 ENAH SCYL1 PRPF6 PSPC1 CEP128 CDC42BPB | 6.09e-08 | 498 | 70 | 10 | 36634849 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MFAP1 PHLDB1 MAP7D1 SFPQ SAFB ARHGAP23 MYO6 SLTM SAFB2 PRPF6 EIF3A UBXN1 MGA ELAC2 PHLDB2 | 6.32e-08 | 1353 | 70 | 15 | 29467282 |
| Pubmed | MFAP1 RBM25 SFPQ SAFB ENAH SLTM SCYL1 SAFB2 PRPF6 CCDC6 PSPC1 | 7.46e-08 | 653 | 70 | 11 | 33742100 | |
| Pubmed | 9.10e-08 | 390 | 70 | 9 | 17643375 | ||
| Pubmed | CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110). | 9.19e-08 | 55 | 70 | 5 | 23178491 | |
| Pubmed | 1.10e-07 | 57 | 70 | 5 | 21555454 | ||
| Pubmed | MFAP1 MAP7D1 RBM25 GSE1 MYO6 PRRC2C FOS CDK11A GIGYF2 EIF3A RERE SNRNP70 MGA TAF1L INO80B | 1.28e-07 | 1429 | 70 | 15 | 35140242 | |
| Pubmed | 1.55e-07 | 551 | 70 | 10 | 34728620 | ||
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 19245811 | ||
| Pubmed | 2.02e-07 | 206 | 70 | 7 | 22174317 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MFAP1 RBM25 SFPQ SAFB LRCH2 BRD4 SLTM SAFB2 PRPF6 CDK11B SNRNP70 PSPC1 CWC22 | 2.18e-07 | 1082 | 70 | 13 | 38697112 |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 2.40e-07 | 315 | 70 | 8 | 26777405 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MFAP1 CACTIN MAP7D1 RBM25 SFPQ SAFB FOS BRD4 SLTM SAFB2 PRPF6 SNRNP70 MGA TAF1L | 2.50e-07 | 1294 | 70 | 14 | 30804502 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CCNE1 STK10 CALD1 ARHGAP23 PPP1R12A SCYL1 CDK11A UPF3B CDK11B UBXN1 CCDC6 TAF1L | 2.53e-07 | 910 | 70 | 12 | 36736316 |
| Pubmed | STK10 MAP7D1 SFPQ SAFB GSE1 PRRC2C BRD4 SAFB2 PRPF6 UPF3B UBXN1 SNRNP70 PSPC1 | 2.72e-07 | 1103 | 70 | 13 | 34189442 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | MFAP1 RBM25 SFPQ SAFB PRRC2C KPNA6 PRPF6 EIF3A CDK11B SNRNP70 | 3.66e-07 | 605 | 70 | 10 | 28977666 |
| Pubmed | 4.52e-07 | 472 | 70 | 9 | 38943005 | ||
| Pubmed | 4.99e-07 | 347 | 70 | 8 | 16033648 | ||
| Pubmed | 5.77e-07 | 486 | 70 | 9 | 20936779 | ||
| Pubmed | 6.83e-07 | 153 | 70 | 6 | 28225217 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | PHLDB1 MAP7D1 MYO6 PPP1R12A CDK11A GIGYF2 KPNA6 PRPF6 CDK11B | 6.94e-07 | 497 | 70 | 9 | 36774506 |
| Pubmed | MFAP1 RBM25 SFPQ GSE1 PRRC2C GIGYF2 PRPF6 RERE SNRNP70 PSPC1 | 7.53e-07 | 655 | 70 | 10 | 35819319 | |
| Pubmed | 7.67e-07 | 503 | 70 | 9 | 16964243 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RBM25 SFPQ CALD1 MYO6 PRRC2C PRPF6 EIF3A UPF3B SNRNP70 PSPC1 ELAC2 | 9.80e-07 | 847 | 70 | 11 | 35235311 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 9.89e-07 | 163 | 70 | 6 | 22113938 | |
| Pubmed | RBM25 SFPQ NF2 MYO6 PPP1R12A PPP1R12B PRPF6 UPF3B SNRNP70 MGA ELAC2 PHLDB2 LRRFIP2 | 1.08e-06 | 1247 | 70 | 13 | 27684187 | |
| Pubmed | 1.42e-06 | 399 | 70 | 8 | 35987950 | ||
| Pubmed | 1.58e-06 | 549 | 70 | 9 | 38280479 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 1.63e-06 | 714 | 70 | 10 | 28302793 | |
| Pubmed | 1.65e-06 | 407 | 70 | 8 | 12693553 | ||
| Pubmed | 1.92e-06 | 44 | 70 | 4 | 26471122 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.76e-06 | 588 | 70 | 9 | 38580884 | |
| Pubmed | MFAP1 CACTIN MAP7D1 RBM25 MYO6 PRRC2C PRPF6 UPF3B CDK11B SNRNP70 PSPC1 CDC42BPB LRRFIP2 | 3.07e-06 | 1371 | 70 | 13 | 36244648 | |
| Pubmed | 3.43e-06 | 202 | 70 | 6 | 24639526 | ||
| Pubmed | 3.54e-06 | 114 | 70 | 5 | 31553912 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 3.57e-06 | 607 | 70 | 9 | 39147351 | |
| Pubmed | 3.97e-06 | 615 | 70 | 9 | 31048545 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20513769 | ||
| Pubmed | Molecular cloning and expression of alternatively spliced PITSLRE protein kinase isoforms. | 3.99e-06 | 2 | 70 | 2 | 8195233 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 14587024 | ||
| Pubmed | Kinases, myosin phosphatase and Rho proteins: curiouser and curiouser. | 3.99e-06 | 2 | 70 | 2 | 10200412 | |
| Pubmed | SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells. | 3.99e-06 | 2 | 70 | 2 | 19901029 | |
| Pubmed | Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. | 3.99e-06 | 2 | 70 | 2 | 10087910 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 7920654 | ||
| Pubmed | Regulated expression of a cell division control-related protein kinase during development. | 3.99e-06 | 2 | 70 | 2 | 2069872 | |
| Pubmed | A cyclin-dependent kinase homologue, p130PITSLRE is a phosphotyrosine-independent SH2 ligand. | 3.99e-06 | 2 | 70 | 2 | 7528743 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 1774066 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25892415 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19077293 | ||
| Pubmed | Low SAFB levels are associated with worse outcome in breast cancer patients. | 3.99e-06 | 2 | 70 | 2 | 19137425 | |
| Pubmed | CDK11p58 Promotes Microglia Activation via Inducing Cyclin D3 Nuclear Localization. | 3.99e-06 | 2 | 70 | 2 | 28101846 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 29530979 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30722725 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16497727 | ||
| Pubmed | Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. | 3.99e-06 | 2 | 70 | 2 | 10882096 | |
| Pubmed | The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer. | 3.99e-06 | 2 | 70 | 2 | 27049727 | |
| Pubmed | Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma. | 3.99e-06 | 2 | 70 | 2 | 32542935 | |
| Pubmed | Structure and expression of the human p58clk-1 protein kinase chromosomal gene. | 3.99e-06 | 2 | 70 | 2 | 1639388 | |
| Pubmed | Protein expression pattern of CDK11(p58) during testicular development in the mouse. | 3.99e-06 | 2 | 70 | 2 | 15792358 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15060143 | ||
| Pubmed | Unravelling the RNA-Binding Properties of SAFB Proteins in Breast Cancer Cells. | 3.99e-06 | 2 | 70 | 2 | 26273616 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26092125 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 32044108 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21144806 | ||
| Pubmed | Expression and functional significance of mouse paraspeckle protein 1 on spermatogenesis. | 3.99e-06 | 2 | 70 | 2 | 15140795 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22566185 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MAP7D1 SFPQ PRRC2C ENAH GIGYF2 KPNA6 PRPF6 EIF3A UPF3B UBXN1 SNRNP70 PSPC1 ELAC2 | 4.33e-06 | 1415 | 70 | 13 | 28515276 |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | 4.47e-06 | 624 | 70 | 9 | 33729478 | |
| Interaction | TAF15 interactions | MFAP1 RBM25 SFPQ SAFB CALD1 NF2 PPP1R12A BRD4 SLTM SAFB2 PRPF6 SNRNP70 PSPC1 DCAF4 | 1.07e-10 | 408 | 70 | 14 | int:TAF15 |
| Interaction | SMC5 interactions | MFAP1 RBM25 SFPQ SAFB CALD1 PRRC2C BRD4 SLTM SAFB2 CDK11A GIGYF2 PRPF6 CDK11B SNRNP70 MGA PSPC1 CWC22 TAF1L INO80B | 7.97e-10 | 1000 | 70 | 19 | int:SMC5 |
| Interaction | NUPR1 interactions | MFAP1 RBM25 SFPQ SAFB CALD1 NF2 MYO6 PPP1R12A SAFB2 CDK11A KPNA6 PRPF6 EIF3A SNRNP70 CWC22 PHLDB2 | 1.15e-09 | 683 | 70 | 16 | int:NUPR1 |
| Interaction | ANKRD50 interactions | 3.75e-09 | 108 | 70 | 8 | int:ANKRD50 | |
| Interaction | E2F4 interactions | KPNA5 CCNE1 MFAP1 RBM25 PPP1R12B BRD4 SLTM SAFB2 PRPF6 EIF3A UBXN1 SNRNP70 MGA PHLDB2 | 4.06e-09 | 540 | 70 | 14 | int:E2F4 |
| Interaction | SNRNP70 interactions | CACTIN MAP7D1 RBM25 SFPQ SAFB MYO6 PRRC2C PPP1R12A BRD4 SLTM SAFB2 PRPF6 UPF3B CDK11B SNRNP70 CWC22 ELAC2 LRRFIP2 | 4.45e-09 | 984 | 70 | 18 | int:SNRNP70 |
| Interaction | DDX23 interactions | MFAP1 CACTIN RBM25 SFPQ SAFB BRD4 SLTM SCYL1 SAFB2 CDK11A PRPF6 SNRNP70 CWC22 | 9.31e-09 | 480 | 70 | 13 | int:DDX23 |
| Interaction | SNRPA interactions | MFAP1 RBM25 SFPQ SAFB ARHGAP23 PRRC2C BRD4 SLTM SAFB2 PRPF6 SNRNP70 CWC22 ENOX2 | 9.78e-09 | 482 | 70 | 13 | int:SNRPA |
| Interaction | RBM25 interactions | MFAP1 RBM25 PRPF40B PPP1R12A BRD4 CDK11A UPF3B CDK11B SNRNP70 PSPC1 CWC22 | 1.41e-08 | 323 | 70 | 11 | int:RBM25 |
| Interaction | CHD4 interactions | KPNA5 MFAP1 RBM25 SFPQ SAFB GSE1 PRRC2C PPP1R12A BRD4 CDK11A GIGYF2 KPNA6 PRPF6 EIF3A CDK11B SNRNP70 CWC22 | 1.50e-08 | 938 | 70 | 17 | int:CHD4 |
| Interaction | SRPK2 interactions | MFAP1 CACTIN PHLDB1 MAP7D1 SAFB GSE1 PRRC2C SLTM PRPF6 EIF3A UPF3B SNRNP70 PSPC1 INO80B ENOX2 | 1.87e-08 | 717 | 70 | 15 | int:SRPK2 |
| Interaction | CPSF6 interactions | MFAP1 RBM25 SFPQ SAFB NF2 BRD4 SLTM SCYL1 SAFB2 PRPF6 SNRNP70 PSPC1 CWC22 | 2.74e-08 | 526 | 70 | 13 | int:CPSF6 |
| Interaction | YWHAE interactions | BEX3 PHLDB1 MAP7D1 SFPQ LRCH2 CALD1 PPP1R12A BRD4 CDK11A GIGYF2 EIF3A JAKMIP1 CDK11B CGNL1 UBXN1 CCDC6 MGA PHLDB2 LRRFIP2 | 3.29e-08 | 1256 | 70 | 19 | int:YWHAE |
| Interaction | SNRPC interactions | MFAP1 CACTIN RBM25 SAFB BRD4 SAFB2 GIGYF2 PRPF6 RERE SNRNP70 CWC22 DCAF4 | 3.42e-08 | 440 | 70 | 12 | int:SNRPC |
| Interaction | FXR1 interactions | MFAP1 ZNF821 PHLDB1 SFPQ PRRC2C BRD4 SAFB2 GIGYF2 EIF3A UPF3B JAKMIP1 PPFIA3 SNRNP70 PSPC1 | 7.18e-08 | 679 | 70 | 14 | int:FXR1 |
| Interaction | ACTC1 interactions | MFAP1 CACTIN RBM25 SFPQ LRCH2 CALD1 MYO6 BRD4 ENAH KPNA6 PRPF6 SNRNP70 PSPC1 LRRFIP2 | 9.39e-08 | 694 | 70 | 14 | int:ACTC1 |
| Interaction | IFI27L1 interactions | 9.92e-08 | 65 | 70 | 6 | int:IFI27L1 | |
| Interaction | CD2BP2 interactions | 1.07e-07 | 232 | 70 | 9 | int:CD2BP2 | |
| Interaction | TNIP1 interactions | CACTIN RBM25 SFPQ SAFB CALD1 NF2 MYO6 PPP1R12A PPP1R12B SLTM SAFB2 CDK11A PRPF6 EIF3A UPF3B CDK11B CCDC6 LRRFIP2 | 1.16e-07 | 1217 | 70 | 18 | int:TNIP1 |
| Interaction | SRSF7 interactions | RBM25 SFPQ SAFB BRD4 SCYL1 CDK11A PRPF6 SNRNP70 CWC22 DCAF4 GRAMD4 | 2.28e-07 | 425 | 70 | 11 | int:SRSF7 |
| Interaction | ZC3H18 interactions | MFAP1 PHLDB1 RBM25 SFPQ SAFB PRRC2C BRD4 SLTM SAFB2 CDK11A PRPF6 EIF3A SNRNP70 PSPC1 CWC22 | 2.59e-07 | 877 | 70 | 15 | int:ZC3H18 |
| Interaction | MEN1 interactions | MFAP1 RBM25 SFPQ SAFB GSE1 FOS SLTM SCYL1 SAFB2 GIGYF2 KPNA6 PRPF6 EIF3A RERE SNRNP70 PSPC1 | 3.49e-07 | 1029 | 70 | 16 | int:MEN1 |
| Interaction | DHX8 interactions | 7.47e-07 | 292 | 70 | 9 | int:DHX8 | |
| Interaction | CSNK2A1 interactions | MFAP1 CACTIN SFPQ SAFB CALD1 PRRC2C FOS BRD4 CDK11A EIF3A UPF3B CDK11B CCDC6 SNRNP70 MGA | 7.74e-07 | 956 | 70 | 15 | int:CSNK2A1 |
| Interaction | KCTD13 interactions | PHLDB1 MAP7D1 SFPQ LRCH2 CALD1 ARHGAP23 MYO6 PRRC2C PPP1R12A PPP1R12B EIF3A UPF3B CGNL1 PPFIA3 PSPC1 CCDC177 CDC42BPB LRRFIP2 | 8.60e-07 | 1394 | 70 | 18 | int:KCTD13 |
| Interaction | IFI16 interactions | MAP7D1 RBM25 SFPQ SAFB BRD4 SLTM SAFB2 EIF3A UPF3B CDK11B SNRNP70 PSPC1 LRRFIP2 | 9.16e-07 | 714 | 70 | 13 | int:IFI16 |
| Interaction | LINC02910 interactions | 9.62e-07 | 95 | 70 | 6 | int:LINC02910 | |
| Interaction | UQCR11 interactions | 1.10e-06 | 53 | 70 | 5 | int:UQCR11 | |
| Interaction | CCNT1 interactions | 1.11e-06 | 225 | 70 | 8 | int:CCNT1 | |
| Interaction | EED interactions | RBM25 SFPQ SAFB MYO6 BRD4 SLTM SCYL1 SAFB2 KPNA6 PRPF6 EIF3A CGNL1 SNRNP70 MGA PSPC1 CWC22 CDC42BPB LRRFIP2 | 1.44e-06 | 1445 | 70 | 18 | int:EED |
| Interaction | NUP43 interactions | MFAP1 CACTIN SAFB GSE1 PRRC2C PPP1R12A PRPF6 CDK11B RERE RILPL1 MGA CWC22 | 1.46e-06 | 625 | 70 | 12 | int:NUP43 |
| Interaction | GATA4 interactions | 1.49e-06 | 411 | 70 | 10 | int:GATA4 | |
| Interaction | PSPC1 interactions | MFAP1 MAP7D1 RBM25 SFPQ NF2 PRRC2C PPP1R12A BRD4 KPNA6 EIF3A PSPC1 | 1.51e-06 | 515 | 70 | 11 | int:PSPC1 |
| Interaction | CEP170 interactions | 1.51e-06 | 318 | 70 | 9 | int:CEP170 | |
| Interaction | EIF3L interactions | 2.04e-06 | 244 | 70 | 8 | int:EIF3L | |
| Interaction | PRPF38B interactions | 2.04e-06 | 108 | 70 | 6 | int:PRPF38B | |
| Interaction | DDX17 interactions | 2.05e-06 | 426 | 70 | 10 | int:DDX17 | |
| Interaction | OBSL1 interactions | MFAP1 MAP7D1 RBM25 SFPQ SAFB CALD1 SLTM SAFB2 PRPF6 EIF3A SNRNP70 MGA PSPC1 PHLDB2 | 2.18e-06 | 902 | 70 | 14 | int:OBSL1 |
| Interaction | CHEK2 interactions | 2.44e-06 | 250 | 70 | 8 | int:CHEK2 | |
| Interaction | KIF20A interactions | MFAP1 RBM25 SFPQ SAFB NF2 MYO6 PPP1R12A BRD4 SAFB2 GIGYF2 PRPF6 EIF3A SNRNP70 CDC42BPB PHLDB2 | 2.55e-06 | 1052 | 70 | 15 | int:KIF20A |
| Interaction | PRMT1 interactions | SFPQ SAFB PRRC2C BRD4 SCYL1 GIGYF2 KPNA6 PRPF6 EIF3A JAKMIP1 CCDC6 SNRNP70 MGA PSPC1 | 3.08e-06 | 929 | 70 | 14 | int:PRMT1 |
| Interaction | PRPF40A interactions | MFAP1 RBM25 SFPQ PPP1R12A BRD4 ENAH CDK11A SNRNP70 PSPC1 CWC22 | 3.09e-06 | 446 | 70 | 10 | int:PRPF40A |
| Interaction | CTTN interactions | MFAP1 RBM25 SFPQ CALD1 MYO6 PPP1R12A BRD4 PRPF6 PSPC1 LRRFIP2 | 3.34e-06 | 450 | 70 | 10 | int:CTTN |
| Interaction | CAPRIN1 interactions | RBM25 SFPQ NF2 PRRC2C PPP1R12A BRD4 GIGYF2 EIF3A SNRNP70 PSPC1 | 3.41e-06 | 451 | 70 | 10 | int:CAPRIN1 |
| Interaction | CDK9 interactions | CCNE1 MFAP1 RBM25 SFPQ SAFB PRRC2C PPP1R12A BRD4 SLTM SNRNP70 PSPC1 LRRFIP2 | 3.77e-06 | 685 | 70 | 12 | int:CDK9 |
| Interaction | TOP2B interactions | 3.86e-06 | 266 | 70 | 8 | int:TOP2B | |
| Interaction | SRRM2 interactions | RBM25 SFPQ NF2 MYO6 PRPF40B PRRC2C PRPF6 SNRNP70 CWC22 DCAF4 | 4.22e-06 | 462 | 70 | 10 | int:SRRM2 |
| Interaction | TOP1 interactions | MFAP1 RBM25 SFPQ SAFB NF2 BRD4 SLTM SAFB2 PRPF6 EIF3A SNRNP70 PSPC1 | 4.44e-06 | 696 | 70 | 12 | int:TOP1 |
| Interaction | YWHAH interactions | RBSN PHLDB1 MAP7D1 LRCH2 PRRC2C PPP1R12A BRD4 GIGYF2 PRPF6 JAKMIP1 CGNL1 CCDC6 CEP128 CWC22 PHLDB2 | 4.49e-06 | 1102 | 70 | 15 | int:YWHAH |
| Interaction | NAA40 interactions | SFPQ SAFB GSE1 CALD1 MYO6 PRRC2C PPP1R12A ENAH SAFB2 GIGYF2 EIF3A UPF3B CGNL1 PSPC1 | 5.57e-06 | 978 | 70 | 14 | int:NAA40 |
| Interaction | TPR interactions | 5.78e-06 | 281 | 70 | 8 | int:TPR | |
| Interaction | EXOSC4 interactions | 6.44e-06 | 202 | 70 | 7 | int:EXOSC4 | |
| Interaction | HMGB1 interactions | 6.59e-06 | 486 | 70 | 10 | int:HMGB1 | |
| Interaction | MEPCE interactions | KPNA5 MFAP1 RBM25 SFPQ ARHGAP23 BRD4 KPNA6 PRPF6 EIF3A UPF3B CDK11B SNRNP70 PSPC1 | 6.98e-06 | 859 | 70 | 13 | int:MEPCE |
| Interaction | CUL4B interactions | CCNE1 RBM25 SFPQ SAFB NF2 PRRC2C BRD4 SAFB2 GIGYF2 SNRNP70 PSPC1 DCAF4 | 7.02e-06 | 728 | 70 | 12 | int:CUL4B |
| Interaction | DCPS interactions | 8.64e-06 | 394 | 70 | 9 | int:DCPS | |
| Interaction | IK interactions | 9.67e-06 | 215 | 70 | 7 | int:IK | |
| Interaction | MYO18A interactions | 1.00e-05 | 303 | 70 | 8 | int:MYO18A | |
| Interaction | PHLDB2 interactions | 1.04e-05 | 143 | 70 | 6 | int:PHLDB2 | |
| Interaction | RBM39 interactions | MFAP1 MAP7D1 RBM25 SFPQ SAFB PRRC2C BRD4 SAFB2 PRPF6 EIF3A SNRNP70 PSPC1 CWC22 INO80B | 1.15e-05 | 1042 | 70 | 14 | int:RBM39 |
| Interaction | SNRNP40 interactions | CACTIN RBM25 GSE1 PRPF40B BRD4 KPNA6 PRPF6 CDK11B SNRNP70 MGA CWC22 | 1.15e-05 | 637 | 70 | 11 | int:SNRNP40 |
| Interaction | ZNF263 interactions | 1.31e-05 | 149 | 70 | 6 | int:ZNF263 | |
| Interaction | SART1 interactions | 1.39e-05 | 317 | 70 | 8 | int:SART1 | |
| Interaction | MYCN interactions | KPNA5 MFAP1 MAP7D1 SFPQ SAFB PRRC2C SLTM SAFB2 CDK11A GRIA3 PRPF6 UPF3B SNRNP70 CWC22 INO80B TMEM63A | 1.46e-05 | 1373 | 70 | 16 | int:MYCN |
| Interaction | BMI1 interactions | CCNE1 PRRC2C BRD4 SLTM SAFB2 GIGYF2 PRPF6 CGNL1 MGA PSPC1 ENOX2 | 1.57e-05 | 659 | 70 | 11 | int:BMI1 |
| Interaction | TFIP11 interactions | 1.64e-05 | 427 | 70 | 9 | int:TFIP11 | |
| Interaction | EZH1 interactions | 1.70e-05 | 92 | 70 | 5 | int:EZH1 | |
| Interaction | PRP4K interactions | 1.81e-05 | 329 | 70 | 8 | int:PRP4K | |
| Interaction | EP300 interactions | MFAP1 RBM25 SFPQ SAFB FOS BRD4 ENAH SLTM SCYL1 SAFB2 PRPF6 RERE CCDC6 SNRNP70 PSPC1 DCAF4 | 1.88e-05 | 1401 | 70 | 16 | int:EP300 |
| Interaction | DOT1L interactions | RBM25 SFPQ SAFB PPP1R12A SLTM SAFB2 GIGYF2 PRPF6 EIF3A PSPC1 INO80B LRRFIP2 | 1.97e-05 | 807 | 70 | 12 | int:DOT1L |
| Interaction | YAP1 interactions | RBM25 SFPQ CALD1 NF2 MYO6 PRRC2C PPP1R12A BRD4 ENAH GIGYF2 EIF3A CCDC6 SNRNP70 MGA | 2.00e-05 | 1095 | 70 | 14 | int:YAP1 |
| Interaction | RBM14 interactions | 2.02e-05 | 553 | 70 | 10 | int:RBM14 | |
| Interaction | EIF3D interactions | 2.19e-05 | 244 | 70 | 7 | int:EIF3D | |
| Interaction | HDAC1 interactions | CCNE1 MAP7D1 RBM25 SFPQ GSE1 NF2 BRD4 GIGYF2 KPNA6 RERE CCDC6 SNRNP70 MGA CEP128 | 2.28e-05 | 1108 | 70 | 14 | int:HDAC1 |
| Interaction | DDX41 interactions | 2.42e-05 | 166 | 70 | 6 | int:DDX41 | |
| Interaction | PRPF19 interactions | 2.48e-05 | 450 | 70 | 9 | int:PRPF19 | |
| Interaction | DHX40 interactions | 2.50e-05 | 249 | 70 | 7 | int:DHX40 | |
| Interaction | RPA4 interactions | 2.57e-05 | 452 | 70 | 9 | int:RPA4 | |
| Interaction | SRRM1 interactions | 2.71e-05 | 348 | 70 | 8 | int:SRRM1 | |
| Interaction | G3BP1 interactions | MFAP1 SAFB MYO6 PRRC2C BRD4 SAFB2 GIGYF2 KPNA6 EIF3A SNRNP70 CWC22 PHLDB2 | 2.75e-05 | 835 | 70 | 12 | int:G3BP1 |
| Interaction | VPS33A interactions | 2.76e-05 | 253 | 70 | 7 | int:VPS33A | |
| Interaction | MECP2 interactions | MFAP1 RBM25 SFPQ SAFB LRCH2 ARHGAP23 PRPF40B BRD4 SLTM SAFB2 PRPF6 CDK11B SNRNP70 PSPC1 CWC22 | 2.85e-05 | 1287 | 70 | 15 | int:MECP2 |
| Interaction | CIT interactions | MFAP1 CACTIN RBM25 SFPQ SAFB NF2 MYO6 PRRC2C PPP1R12A SAFB2 CDK11A PRPF6 EIF3A UPF3B SNRNP70 PSPC1 | 2.86e-05 | 1450 | 70 | 16 | int:CIT |
| Interaction | GAGE5 interactions | 3.19e-05 | 52 | 70 | 4 | int:GAGE5 | |
| Interaction | LGR4 interactions | 3.45e-05 | 262 | 70 | 7 | int:LGR4 | |
| Interaction | CDK1 interactions | CCNE1 MFAP1 SAFB CALD1 NF2 PPP1R12A BRD4 SAFB2 CCDC6 SNRNP70 | 3.50e-05 | 590 | 70 | 10 | int:CDK1 |
| Interaction | EIF3C interactions | 3.54e-05 | 263 | 70 | 7 | int:EIF3C | |
| Interaction | SAA1 interactions | 3.70e-05 | 54 | 70 | 4 | int:SAA1 | |
| Interaction | YWHAZ interactions | MFAP1 PHLDB1 MAP7D1 SFPQ PPP1R12A BRD4 ENAH GIGYF2 EIF3A JAKMIP1 CDK11B CGNL1 PPFIA3 CCDC6 PHLDB2 | 3.79e-05 | 1319 | 70 | 15 | int:YWHAZ |
| Interaction | ATG16L1 interactions | CACTIN RBSN PHLDB1 SAFB TCHP PRRC2C PPP1R12A SLTM SAFB2 EIF3A CCDC6 CWC22 PHLDB2 LRRFIP2 | 3.81e-05 | 1161 | 70 | 14 | int:ATG16L1 |
| Interaction | EXOSC2 interactions | 3.81e-05 | 180 | 70 | 6 | int:EXOSC2 | |
| Interaction | POLR3C interactions | 4.03e-05 | 110 | 70 | 5 | int:POLR3C | |
| Interaction | EIF3M interactions | 4.06e-05 | 182 | 70 | 6 | int:EIF3M | |
| Interaction | BZW1 interactions | 4.18e-05 | 183 | 70 | 6 | int:BZW1 | |
| Interaction | CDK11B interactions | 4.18e-05 | 183 | 70 | 6 | int:CDK11B | |
| Interaction | SREK1 interactions | 4.18e-05 | 183 | 70 | 6 | int:SREK1 | |
| Interaction | PPP1CC interactions | MAP7D1 CALD1 MYO6 PPP1R12A PPP1R12B SAFB2 KPNA6 CCDC6 SNRNP70 PSPC1 LRRFIP2 | 4.45e-05 | 738 | 70 | 11 | int:PPP1CC |
| Interaction | ZFP41 interactions | 4.59e-05 | 57 | 70 | 4 | int:ZFP41 | |
| Interaction | NXF1 interactions | KPNA5 STK10 CACTIN RBM25 SFPQ NF2 MYO6 BRD4 SCYL1 UPF3B UBXN1 SNRNP70 CEP128 TAF1L ENOX2 | 4.74e-05 | 1345 | 70 | 15 | int:NXF1 |
| Interaction | PRPF40B interactions | 5.10e-05 | 21 | 70 | 3 | int:PRPF40B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q24 | 2.56e-04 | 200 | 70 | 4 | chr14q24 | |
| Cytoband | 1q42.12 | 3.45e-04 | 18 | 70 | 2 | 1q42.12 | |
| Cytoband | 14q24.3 | 3.99e-04 | 93 | 70 | 3 | 14q24.3 | |
| GeneFamily | RNA binding motif containing | 1.46e-08 | 213 | 39 | 8 | 725 | |
| GeneFamily | Armadillo repeat containing|Importins | 6.79e-04 | 18 | 39 | 2 | 596 | |
| GeneFamily | Cyclin dependent kinases | 1.43e-03 | 26 | 39 | 2 | 496 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.87e-03 | 43 | 39 | 2 | 409 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 5.83e-03 | 53 | 39 | 2 | 103 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.92e-03 | 181 | 39 | 3 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.85e-03 | 206 | 39 | 3 | 682 | |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 9.10e-07 | 28 | 70 | 4 | MM1323 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 1.65e-06 | 417 | 70 | 9 | M39224 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.10e-06 | 221 | 70 | 7 | M39222 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 5.55e-06 | 484 | 70 | 9 | MM999 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 1.02e-05 | 394 | 70 | 8 | MM3724 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | 2.40e-05 | 444 | 70 | 8 | M41713 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_GRANULOCYTE_AGEING | 3.03e-05 | 224 | 70 | 6 | MM3836 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PHLDB1 RBM25 ARHGAP23 MYO6 PRRC2C FOS PPP1R12B PSPC1 CEP128 INO80B PHLDB2 TMEM63A | 3.21e-05 | 1102 | 70 | 12 | M2369 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 3.43e-05 | 467 | 70 | 8 | M1347 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | PHLDB1 RBM25 ARHGAP23 MYO6 PRRC2C FOS PPP1R12B PSPC1 CEP128 INO80B PHLDB2 TMEM63A | 3.89e-05 | 1124 | 70 | 12 | MM1070 |
| Coexpression | REICHERT_MITOSIS_LIN9_TARGETS | 5.10e-05 | 27 | 70 | 3 | M2483 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 6.97e-05 | 380 | 70 | 7 | M41703 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.00e-04 | 90 | 70 | 4 | M39250 | |
| Coexpression | HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP | 1.13e-04 | 177 | 70 | 5 | M6564 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS | 1.14e-04 | 93 | 70 | 4 | M39279 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 1.34e-04 | 568 | 70 | 8 | MM3824 | |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 1.42e-04 | 186 | 70 | 5 | M4911 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | 1.75e-04 | 441 | 70 | 7 | M172 | |
| Coexpression | BROWNE_HCMV_INFECTION_8HR_UP | 1.82e-04 | 105 | 70 | 4 | M10695 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | CACTIN RBM25 SFPQ BRD4 SLTM SCYL1 KPNA6 EIF3A RERE UBXN1 SNRNP70 | 1.89e-04 | 1129 | 70 | 11 | M42508 |
| Coexpression | GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN | 1.95e-04 | 199 | 70 | 5 | M7351 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP | 1.99e-04 | 200 | 70 | 5 | M7745 | |
| Coexpression | GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP | 1.99e-04 | 200 | 70 | 5 | M9397 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN | 1.99e-04 | 200 | 70 | 5 | M8427 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | CACTIN RBM25 SFPQ BRD4 SLTM SCYL1 KPNA6 EIF3A RERE UBXN1 SNRNP70 | 2.36e-04 | 1158 | 70 | 11 | MM1338 |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP | 2.41e-04 | 113 | 70 | 4 | M1260 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 2.72e-04 | 474 | 70 | 7 | M40991 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 2.88e-04 | 338 | 70 | 6 | M17094 | |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 3.29e-04 | 223 | 70 | 5 | M17621 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 3.30e-04 | 822 | 70 | 9 | M6782 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 8.31e-06 | 311 | 70 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MFAP1 RBSN SAFB ENAH SLTM SAFB2 PRPF6 EIF3A UPF3B CDK11B RERE LRRFIP2 | 1.57e-05 | 831 | 70 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_500 | 4.59e-05 | 60 | 70 | 4 | gudmap_developingGonad_e12.5_ovary_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.68e-05 | 136 | 70 | 5 | gudmap_developingGonad_P2_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 9.41e-05 | 72 | 70 | 4 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.38e-04 | 150 | 70 | 5 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.65e-04 | 156 | 70 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | RBM25 SFPQ LRCH2 CALD1 BRD4 ENAH SLTM PRPF6 EIF3A UPF3B CDK11B PSPC1 CEP128 | 2.00e-04 | 1252 | 70 | 13 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CCNE1 RBM25 SFPQ LRCH2 BRD4 ENAH SLTM PRPF6 EIF3A UPF3B CDK11B PSPC1 CEP128 | 2.07e-04 | 1257 | 70 | 13 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.12e-04 | 259 | 70 | 6 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.14e-04 | 89 | 70 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CCNE1 RBM25 SFPQ LRCH2 BRD4 ENAH SLTM PRPF6 EIF3A UPF3B CDK11B PSPC1 CEP128 CWC22 | 2.49e-04 | 1459 | 70 | 14 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.38e-04 | 182 | 70 | 5 | gudmap_developingGonad_e16.5_ovary_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.95e-04 | 291 | 70 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.03e-04 | 105 | 70 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.31e-04 | 192 | 70 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.31e-04 | 192 | 70 | 5 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.48e-04 | 298 | 70 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.46e-04 | 432 | 70 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_500 | 5.50e-04 | 114 | 70 | 4 | gudmap_developingGonad_e12.5_epididymis_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.48e-04 | 210 | 70 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | RBM25 SFPQ LRCH2 ENAH SLTM EIF3A UPF3B CDK11B PSPC1 CEP128 ENOX2 | 6.58e-04 | 1060 | 70 | 11 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_500 | 7.14e-04 | 53 | 70 | 3 | gudmap_developingGonad_P2_epididymis_500_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.14e-04 | 53 | 70 | 3 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.54e-04 | 124 | 70 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k1 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.54e-11 | 197 | 70 | 9 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.21e-08 | 192 | 70 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.27e-07 | 182 | 70 | 6 | 728a2152c166551ac229370c0900fe2bc426ea9b | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 7.19e-07 | 199 | 70 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.00e-06 | 169 | 70 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 188 | 70 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-05 | 190 | 70 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 194 | 70 | 5 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 194 | 70 | 5 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-05 | 195 | 70 | 5 | 55b4030f078173b0136990fae87b6eaf44c58f33 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 195 | 70 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-05 | 195 | 70 | 5 | 19347b7e8d3ea67e0fddd948078abcab9d364a2d | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 195 | 70 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 197 | 70 | 5 | 94a7270ea6d4b586f58875c9e4071ce0f683ef7e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 197 | 70 | 5 | 68c23c23b6924892f4c238cf2f5abc7927e04fbc | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.54e-05 | 199 | 70 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-05 | 199 | 70 | 5 | 4217b9e66c5374461e84bdb893ab650f148286c8 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.54e-05 | 199 | 70 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.94e-05 | 149 | 70 | 4 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.04e-04 | 155 | 70 | 4 | e2c901d5c9e42d25d7702e5e8fc19b06f7c817be | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.32e-04 | 165 | 70 | 4 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.36e-04 | 166 | 70 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.42e-04 | 168 | 70 | 4 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-04 | 170 | 70 | 4 | dfef8f79960979335b86b4730f224239b40735d5 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-04 | 170 | 70 | 4 | fb6098137d010175978596bc382e9ecba9c3891e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 171 | 70 | 4 | fe0665c5ca01b0b2cc8f20d64587f0847c3d215c | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 173 | 70 | 4 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 173 | 70 | 4 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.62e-04 | 174 | 70 | 4 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-04 | 175 | 70 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 177 | 70 | 4 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 179 | 70 | 4 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.89e-04 | 181 | 70 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-04 | 183 | 70 | 4 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 183 | 70 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 183 | 70 | 4 | 8de4b616a06be03e1cb6ae6a9ce6bf06485629d3 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.01e-04 | 184 | 70 | 4 | 437bc6c983849c1c3ff85f0dee091cf7010a4665 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 184 | 70 | 4 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-04 | 184 | 70 | 4 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.01e-04 | 184 | 70 | 4 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 2.01e-04 | 184 | 70 | 4 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.01e-04 | 184 | 70 | 4 | d1d5dd1701dff4eedf1cebbb9f4cd603aa0009c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 184 | 70 | 4 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.10e-04 | 186 | 70 | 4 | ed9b1a784f67e8a297e2a10993a6d97df60581ac | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 186 | 70 | 4 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.10e-04 | 186 | 70 | 4 | fbc4ba4a7a8e5902a1b0add52ece0d6da85a8a5f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.10e-04 | 186 | 70 | 4 | c793a3d5709ad504c12fc3b2337746d90236d3ca | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-04 | 186 | 70 | 4 | d57c40b3fe5cfc87e771df76533d9a3e94678b04 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 187 | 70 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-04 | 187 | 70 | 4 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.14e-04 | 187 | 70 | 4 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-04 | 187 | 70 | 4 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-04 | 187 | 70 | 4 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.18e-04 | 188 | 70 | 4 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-04 | 188 | 70 | 4 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.18e-04 | 188 | 70 | 4 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-04 | 189 | 70 | 4 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-04 | 189 | 70 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-04 | 189 | 70 | 4 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-04 | 189 | 70 | 4 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-04 | 189 | 70 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 2.32e-04 | 191 | 70 | 4 | 2da83c493e60ad0278848957645277d76737a188 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 191 | 70 | 4 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 2.32e-04 | 191 | 70 | 4 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 192 | 70 | 4 | 43228bddca2f606ddcae9731f04c6b1502c4b85a | |
| ToppCell | Control-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 2.36e-04 | 192 | 70 | 4 | f95fb188aa642f3d0618242a770e7c4b70544adb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 192 | 70 | 4 | f5463c6bcc5c69ac562bec028f7a105c471f2fbe | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 192 | 70 | 4 | 20fd69eb60b93d22d9be39de44b733db6d761dde | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-04 | 192 | 70 | 4 | d0fb6885f023d55a2b7984c99db9c6463258f788 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-04 | 192 | 70 | 4 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 2.41e-04 | 193 | 70 | 4 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-04 | 193 | 70 | 4 | 4aa976b596830b585e8d9c808d5072ed23d13a7c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-04 | 193 | 70 | 4 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-04 | 193 | 70 | 4 | 5578f7cb3ec68c9a38cc5304b618b81283024d5e | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-04 | 193 | 70 | 4 | a402e736440684ebe123673b6b0c6fcd8fa057b2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-04 | 193 | 70 | 4 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Control-Endothelial-Lymphatic|Control / Disease state, Lineage and Cell class | 2.41e-04 | 193 | 70 | 4 | 64d19be73e5432d491436a01da5de5c926b615a9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-04 | 193 | 70 | 4 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-04 | 194 | 70 | 4 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-04 | 194 | 70 | 4 | 93bc72a933ccc6a760e5353f072afb606571c6fc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 194 | 70 | 4 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | CV-Severe-6|CV / Virus stimulation, Condition and Cluster | 2.51e-04 | 195 | 70 | 4 | 69095c6ce2a7e763afa543c10d5710e0c3dda769 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.56e-04 | 196 | 70 | 4 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 196 | 70 | 4 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 196 | 70 | 4 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | droplet-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 196 | 70 | 4 | b880c9665d42c76ea1971d4e49d7ecf72fcfafb6 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 2.61e-04 | 197 | 70 | 4 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-04 | 197 | 70 | 4 | d16bb765afdc02406ffd7ce6a75bae72b66db66c | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 197 | 70 | 4 | aafe279b14cdcb786bc45524bc3c26261128ee48 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 197 | 70 | 4 | fb14da600f563273059a4683a5079af81aca0886 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 197 | 70 | 4 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.66e-04 | 198 | 70 | 4 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 198 | 70 | 4 | 27f0654fb0857e93f030e1a4b1c307b31576bbcd | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.66e-04 | 198 | 70 | 4 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.66e-04 | 198 | 70 | 4 | 89986c7756541df364df516329d10775ba0e78a4 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.66e-04 | 198 | 70 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 198 | 70 | 4 | fef9a4c96450078527b94d25e681410e4ea01b13 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-04 | 198 | 70 | 4 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.66e-04 | 198 | 70 | 4 | 08d393853e195a7eacace454153e425a273e2d23 | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 2.66e-04 | 198 | 70 | 4 | 86a4c8e859ce11a95875f8844963baeb1ba898ec | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.76e-07 | 199 | 70 | 8 | 4526_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 2.23e-06 | 194 | 70 | 7 | 5454_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.55e-06 | 198 | 70 | 7 | 3326_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HT_HG-U133A | 2.64e-06 | 199 | 70 | 7 | 6287_UP | |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; HL60; HT_HG-U133A | 2.64e-06 | 199 | 70 | 7 | 2363_UP | |
| Drug | 2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 2.64e-06 | 199 | 70 | 7 | 3570_UP | |
| Drug | 2-phenylindole | 7.79e-06 | 13 | 70 | 3 | CID000013698 | |
| Drug | LY354740 | 1.84e-05 | 51 | 70 | 4 | CID000114827 | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.79e-05 | 192 | 70 | 6 | 3753_DN | |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A | 2.95e-05 | 194 | 70 | 6 | 5483_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.04e-05 | 195 | 70 | 6 | 3191_DN | |
| Drug | Crotamiton [483-63-6]; Down 200; 19.6uM; HL60; HT_HG-U133A | 3.04e-05 | 195 | 70 | 6 | 3050_DN | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 1695_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 6775_DN | |
| Drug | Hemicholinium bromide [312-45-8]; Up 200; 7uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 5339_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 6229_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 3442_UP | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 6787_DN | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 6094_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 1219_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 6611_DN | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; PC3; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 6306_UP | |
| Drug | prazosin hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.22e-05 | 197 | 70 | 6 | 826_UP | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 6360_DN | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 4814_DN | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; PC3; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 4077_UP | |
| Drug | Cefoperazone dihydrate; Up 200; 5.8uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6323_UP | |
| Drug | cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Down 200; 100uM; PC3; HG-U133A | 3.31e-05 | 198 | 70 | 6 | 664_DN | |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 7261_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; HL60; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 2364_DN | |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 7127_UP | |
| Drug | estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 1208_UP | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 5886_UP | |
| Drug | 5-aminosalicylic acid; Down 200; 100uM; MCF7; HG-U133A | 3.31e-05 | 198 | 70 | 6 | 124_DN | |
| Drug | Zoxazolamine [61-80-3]; Down 200; 23.8uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6290_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6230_UP | |
| Drug | Chlorpropamide [94-20-2]; Up 200; 14.4uM; PC3; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6291_UP | |
| Drug | Ethionamide [536-33-4]; Down 200; 24uM; PC3; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 4593_DN | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 4197_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; PC3; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 7284_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 6814_DN | |
| Drug | Dubinidine [22964-77-8]; Down 200; 14.6uM; PC3; HT_HG-U133A | 3.50e-05 | 200 | 70 | 6 | 5774_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 100uM; HL60; HG-U133A | 3.50e-05 | 200 | 70 | 6 | 363_DN | |
| Drug | AC1NRBPQ | 6.48e-05 | 137 | 70 | 5 | CID005288569 | |
| Drug | MCDF | 8.63e-05 | 28 | 70 | 3 | CID000114900 | |
| Drug | pSAP | 1.39e-04 | 6 | 70 | 2 | CID000007171 | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.43e-04 | 162 | 70 | 5 | 1339_UP | |
| Drug | geldanamycin | 1.43e-04 | 371 | 70 | 7 | ctd:C001277 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.51e-04 | 164 | 70 | 5 | 3852_UP | |
| Drug | Fendiline hydrochloride [13636-18-5]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.51e-04 | 164 | 70 | 5 | 7188_UP | |
| Drug | 4-(3,6-dimethylheptan-3-yl)phenol | 1.56e-04 | 34 | 70 | 3 | CID010633340 | |
| Drug | CI628M | 1.94e-04 | 7 | 70 | 2 | CID003035794 | |
| Drug | troglitazone; Up 200; 10uM; PC3; HT_HG-U133A | 1.94e-04 | 173 | 70 | 5 | 1232_UP | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.16e-04 | 177 | 70 | 5 | 985_DN | |
| Drug | AC1L1GHE | 2.20e-04 | 96 | 70 | 4 | CID000003684 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.22e-04 | 178 | 70 | 5 | 3998_DN | |
| Drug | S-2-pentyl-4-pentynoic hydroxamic acid | STK10 PHLDB1 RBM25 TMEM53 PPP1R12A ENAH EIF3A JAKMIP1 RERE TMEM63A | 2.23e-04 | 834 | 70 | 10 | ctd:C513635 |
| Drug | 4-hydroxyethynylestradiol | 2.58e-04 | 8 | 70 | 2 | CID000066396 | |
| Drug | N-methyldehydroalanine | 2.58e-04 | 8 | 70 | 2 | CID000134856 | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.58e-04 | 184 | 70 | 5 | 4349_DN | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; PC3; HT_HG-U133A | 2.65e-04 | 185 | 70 | 5 | 1215_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.78e-04 | 187 | 70 | 5 | 3240_UP | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.92e-04 | 189 | 70 | 5 | 836_UP | |
| Drug | Leflunomide [75706-12-6]; Up 200; 14.8uM; HL60; HT_HG-U133A | 2.99e-04 | 190 | 70 | 5 | 2539_UP | |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.99e-04 | 190 | 70 | 5 | 3172_DN | |
| Drug | ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A | 3.07e-04 | 191 | 70 | 5 | 1663_UP | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 2081_DN | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 4449_DN | |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 7004_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 2292_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 1209_UP | |
| Drug | Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.14e-04 | 192 | 70 | 5 | 3505_DN | |
| Drug | tert-butylthio | 3.14e-04 | 43 | 70 | 3 | CID000006387 | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; PC3; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 4558_DN | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 3.22e-04 | 193 | 70 | 5 | 4973_DN | |
| Drug | Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 2863_DN | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 1uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 4715_DN | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 4572_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 2293_DN | |
| Drug | Streptozotocin [18883-66-4]; Up 200; 15uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 5836_UP | |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 7247_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 3384_DN | |
| Drug | Omeprazole [73590-58-6]; Down 200; 11.6uM; HL60; HT_HG-U133A | 3.30e-04 | 194 | 70 | 5 | 2467_DN | |
| Drug | U23,469 | 3.31e-04 | 9 | 70 | 2 | CID000161922 | |
| Drug | S-V3 | 3.31e-04 | 9 | 70 | 2 | CID000209655 | |
| Drug | TMBs | 3.31e-04 | 9 | 70 | 2 | CID000076113 | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 7135_UP | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 4533_DN | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 5447_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; PC3; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 7393_DN | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 2884_DN | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 7559_UP | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 5269_DN | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 3.37e-04 | 195 | 70 | 5 | 421_UP | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 3.37e-04 | 195 | 70 | 5 | 1527_DN | |
| Drug | K-Cl | 3.42e-04 | 567 | 70 | 8 | CID000004873 | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 3.45e-04 | 196 | 70 | 5 | 2_DN | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 3271_DN | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.45e-04 | 196 | 70 | 5 | 2784_UP | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; HL60; HG-U133A | 3.45e-04 | 196 | 70 | 5 | 1982_UP | |
| Disease | serum gamma-glutamyl transferase measurement | 2.16e-04 | 914 | 67 | 9 | EFO_0004532 | |
| Disease | Alopecia, Male Pattern | 5.23e-04 | 15 | 67 | 2 | C4083212 | |
| Disease | Androgenetic Alopecia | 5.23e-04 | 15 | 67 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 5.23e-04 | 15 | 67 | 2 | C0263477 | |
| Disease | Pseudopelade | 8.47e-04 | 19 | 67 | 2 | C0086873 | |
| Disease | Alopecia | 8.47e-04 | 19 | 67 | 2 | C0002170 | |
| Disease | neuroticism measurement, cognitive function measurement | 1.80e-03 | 566 | 67 | 6 | EFO_0007660, EFO_0008354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MESKRLRLLQEEDRR | 101 | Q8WV16 | |
| ERRLQELEREMRTER | 221 | Q6ZU80 | |
| ELEREMRTERELVER | 226 | Q6ZU80 | |
| MEEMREIRRKLRELQ | 71 | Q00994 | |
| EKERLRQERMRSRED | 1251 | O60885 | |
| LQMDEELRRERERER | 331 | Q14687 | |
| RQELDRERQRRMELE | 111 | Q6IC98 | |
| MPRERRERDAKERDT | 1 | P24864 | |
| RKLQREMERREALCR | 306 | Q16204 | |
| LERKRERERKMREQQ | 171 | P21127 | |
| EMRRRREEEGIQLRK | 26 | O15131 | |
| REEERRREMAKEAKR | 481 | P49756 | |
| QLQMLRERELERERE | 521 | Q9H1K0 | |
| RKRERMESEERERQE | 96 | Q7L8S5 | |
| EAMRRRKEEEERRAR | 976 | Q86T65 | |
| EMRRRREEEGIQLRK | 26 | O60684 | |
| RHERLREKMRRRLES | 41 | P42898 | |
| RMRNLTEEERRAELR | 306 | P55081 | |
| NERRRRGEMRDLFEK | 2431 | Q8IWI9 | |
| EEEKRRIRRERNKMA | 136 | P01100 | |
| LDEKVRERLRMALER | 166 | O75145 | |
| LAREERHRRRMEEER | 221 | Q16206 | |
| MESRNRDREKRRERE | 66 | Q9HCG8 | |
| EFRRIIEEMDRRQEK | 201 | P42263 | |
| TERDIEMKRQLRRLR | 6 | Q9UHL3 | |
| RIKRECERDIRRLMD | 196 | Q96N16 | |
| RQEMRRAEKLRKELE | 616 | Q9Y5S2 | |
| RMKDRLLERITEEER | 326 | O94886 | |
| ARAEARDIRMRELER | 41 | Q9Y608 | |
| EMLLKREERARKRRL | 211 | Q9C086 | |
| RTRDELERRLLQMKE | 351 | P35240 | |
| NKQRMREEKREERRR | 206 | Q9BZI7 | |
| RREAEMRAKREEEER | 741 | Q6Y7W6 | |
| QMLKEREERERAERA | 821 | Q14152 | |
| KEERERMRANLEELR | 641 | Q0VF96 | |
| REMVKLRREIIERRR | 251 | Q8NCU4 | |
| LEQLERKRERERKMR | 156 | Q9UQ88 | |
| QERRKRLEEIMKRTR | 706 | Q3KQU3 | |
| RLEREREKAMREQEL | 251 | Q8WUQ7 | |
| ERERIMREEKRRLFT | 151 | Q9NQR7 | |
| LERERLERERMERER | 156 | Q8N8S7 | |
| LERERMERERLERER | 161 | Q8N8S7 | |
| MERERLERERLERER | 166 | Q8N8S7 | |
| RRKMEHLREEREQIR | 636 | Q5VUJ6 | |
| ETREERMERKRREKI | 61 | P08621 | |
| RMERKRREKIERRQQ | 66 | P08621 | |
| ERRREMEAKRAERKV | 781 | Q96KG9 | |
| RMDERRKERREQREK | 111 | O94906 | |
| REEMRKERRRIQEQL | 1236 | Q8IZX4 | |
| DRIITREKDMRRVRD | 516 | Q96NG3 | |
| RARKRREEEERRMEE | 461 | Q9Y520 | |
| RLEIERQKLERERME | 666 | Q9NWH9 | |
| RQKLERERMERERLE | 671 | Q9NWH9 | |
| RERMERERLERERIR | 676 | Q9NWH9 | |
| EREIRERELRERMKP | 1311 | Q9P2R6 | |
| RQREERLREQEMERL | 431 | Q86SQ0 | |
| RLREQEMERLERQRL | 436 | Q86SQ0 | |
| DMRRRLRELTREVEA | 266 | Q8N4L4 | |
| RQRLERERMERERLE | 656 | Q15424 | |
| RERMERERLERERMH | 661 | Q15424 | |
| MDDFERRRELRRQKR | 1 | Q05682 | |
| RRRELRRQKREEMRL | 6 | Q05682 | |
| RRQKREEMRLEAERI | 11 | Q05682 | |
| RMREEEKRAAEERQR | 316 | Q05682 | |
| KEMQLRQEEERRRRE | 561 | P23246 | |
| EEMEERREKRELRQV | 776 | Q9BQ52 | |
| RLRLERMDRIEKERK | 86 | Q5EBL4 | |
| RQDLMRRQEELRRLE | 321 | Q8WXF1 | |
| RIEDARERMRTLRKL | 1006 | Q9P227 | |
| EEMRFLRRQELRELR | 556 | O94804 | |
| RDIERMVEARLARRV | 226 | Q6P2H8 | |
| REREKEEARRMRRRE | 616 | Q6NWY9 | |
| RSEEKAMREREERRI | 131 | P53801 | |
| EERRIRQEERRAEMK | 141 | P53801 | |
| REALERMKAEEERRQ | 196 | Q9BT92 | |
| RLERERMERERLERE | 676 | Q14151 | |
| RMERERLERERMRVE | 681 | Q14151 | |
| RLERERMRVERERRK | 686 | Q14151 | |
| RMRVERERRKEQERI | 691 | Q14151 | |
| LREQEMERLERQRLE | 601 | Q86UU1 | |
| REMELRRQALEEERR | 1171 | Q86UU1 | |
| DEMRRAAEERRREKA | 141 | Q04323 | |
| EEREVRRMRDREAKR | 291 | O75541 | |
| RARRLQRDREAMRLK | 316 | O75541 | |
| LRRIQEEMEKERKRR | 926 | Q9UM54 | |
| RRRKEEEERRMKLEM | 946 | Q9UM54 | |
| EMEKRERRALERRIS | 981 | O14974 | |
| VLEMEKRERRALERK | 931 | O60237 |